| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | protein domain specific binding | 4.66e-04 | 875 | 16 | 5 | GO:0019904 | |
| GeneOntologyMolecularFunction | ABC-type transporter activity | 6.93e-04 | 49 | 16 | 2 | GO:0140359 | |
| GeneOntologyMolecularFunction | ATPase-coupled transmembrane transporter activity | 3.37e-03 | 109 | 16 | 2 | GO:0042626 | |
| GeneOntologyBiologicalProcess | positive regulation of mast cell proliferation | 8.45e-06 | 6 | 16 | 2 | GO:0070668 | |
| GeneOntologyBiologicalProcess | mast cell proliferation | 2.02e-05 | 9 | 16 | 2 | GO:0070662 | |
| GeneOntologyBiologicalProcess | regulation of mast cell proliferation | 2.02e-05 | 9 | 16 | 2 | GO:0070666 | |
| GeneOntologyBiologicalProcess | regulation of tyrosine phosphorylation of STAT protein | 3.64e-05 | 85 | 16 | 3 | GO:0042509 | |
| GeneOntologyBiologicalProcess | tyrosine phosphorylation of STAT protein | 4.32e-05 | 90 | 16 | 3 | GO:0007260 | |
| GeneOntologyBiologicalProcess | tube development | 4.38e-05 | 1402 | 16 | 7 | GO:0035295 | |
| GeneOntologyBiologicalProcess | mast cell activation | 6.09e-05 | 101 | 16 | 3 | GO:0045576 | |
| GeneOntologyBiologicalProcess | anatomical structure formation involved in morphogenesis | 6.28e-05 | 1483 | 16 | 7 | GO:0048646 | |
| GeneOntologyBiologicalProcess | ectopic germ cell programmed cell death | 1.17e-04 | 21 | 16 | 2 | GO:0035234 | |
| GeneOntologyBiologicalProcess | regulation of protein phosphorylation | 1.35e-04 | 1133 | 16 | 6 | GO:0001932 | |
| GeneOntologyBiologicalProcess | regulation of mast cell activation | 1.54e-04 | 24 | 16 | 2 | GO:0033003 | |
| GeneOntologyBiologicalProcess | immature B cell differentiation | 1.67e-04 | 25 | 16 | 2 | GO:0002327 | |
| GeneOntologyBiologicalProcess | lymphoid progenitor cell differentiation | 1.81e-04 | 26 | 16 | 2 | GO:0002320 | |
| GeneOntologyBiologicalProcess | regulation of phosphorylation | 2.08e-04 | 1226 | 16 | 6 | GO:0042325 | |
| GeneOntologyBiologicalProcess | programmed cell death involved in cell development | 2.76e-04 | 32 | 16 | 2 | GO:0010623 | |
| GeneOntologyBiologicalProcess | erythrocyte differentiation | 3.15e-04 | 176 | 16 | 3 | GO:0030218 | |
| GeneOntologyBiologicalProcess | positive regulation of cellular component organization | 3.75e-04 | 1366 | 16 | 6 | GO:0051130 | |
| GeneOntologyBiologicalProcess | erythrocyte homeostasis | 3.94e-04 | 190 | 16 | 3 | GO:0034101 | |
| GeneOntologyBiologicalProcess | regulation of MAP kinase activity | 4.19e-04 | 194 | 16 | 3 | GO:0043405 | |
| GeneOntologyBiologicalProcess | hematopoietic progenitor cell differentiation | 4.38e-04 | 197 | 16 | 3 | GO:0002244 | |
| GeneOntologyBiologicalProcess | cell surface receptor signaling pathway via JAK-STAT | 4.45e-04 | 198 | 16 | 3 | GO:0007259 | |
| GeneOntologyBiologicalProcess | regulation of phosphate metabolic process | 4.64e-04 | 1421 | 16 | 6 | GO:0019220 | |
| GeneOntologyBiologicalProcess | regulation of phosphorus metabolic process | 4.68e-04 | 1423 | 16 | 6 | GO:0051174 | |
| GeneOntologyBiologicalProcess | lipid transport | 5.15e-04 | 506 | 16 | 4 | GO:0006869 | |
| GeneOntologyBiologicalProcess | cell surface receptor signaling pathway via STAT | 5.74e-04 | 216 | 16 | 3 | GO:0097696 | |
| GeneOntologyBiologicalProcess | regulation of protein modification process | 5.95e-04 | 1488 | 16 | 6 | GO:0031399 | |
| GeneOntologyBiologicalProcess | myeloid cell homeostasis | 7.79e-04 | 240 | 16 | 3 | GO:0002262 | |
| GeneOntologyBiologicalProcess | lipid localization | 7.80e-04 | 565 | 16 | 4 | GO:0010876 | |
| GeneOntologyBiologicalProcess | cytokine-mediated signaling pathway | 8.44e-04 | 577 | 16 | 4 | GO:0019221 | |
| GeneOntologyBiologicalProcess | multicellular organismal-level homeostasis | 8.96e-04 | 1043 | 16 | 5 | GO:0048871 | |
| GeneOntologyBiologicalProcess | regulation of erythrocyte differentiation | 9.73e-04 | 60 | 16 | 2 | GO:0045646 | |
| GeneOntologyBiologicalProcess | regulation of glial cell proliferation | 1.04e-03 | 62 | 16 | 2 | GO:0060251 | |
| GeneOntologyBiologicalProcess | Fc receptor signaling pathway | 1.04e-03 | 62 | 16 | 2 | GO:0038093 | |
| GeneOntologyBiologicalProcess | regulation of protein kinase activity | 1.04e-03 | 611 | 16 | 4 | GO:0045859 | |
| GeneOntologyBiologicalProcess | positive regulation of cell development | 1.06e-03 | 614 | 16 | 4 | GO:0010720 | |
| GeneOntologyBiologicalProcess | immune response-regulating signaling pathway | 1.07e-03 | 615 | 16 | 4 | GO:0002764 | |
| GeneOntologyBiologicalProcess | regulation of cell development | 1.12e-03 | 1095 | 16 | 5 | GO:0060284 | |
| GeneOntologyBiologicalProcess | regulation of peptidyl-tyrosine phosphorylation | 1.12e-03 | 272 | 16 | 3 | GO:0050730 | |
| GeneOntologyBiologicalProcess | positive regulation of tyrosine phosphorylation of STAT protein | 1.28e-03 | 69 | 16 | 2 | GO:0042531 | |
| GeneOntologyBiologicalProcess | positive regulation of cell differentiation | 1.34e-03 | 1141 | 16 | 5 | GO:0045597 | |
| GeneOntologyBiologicalProcess | pattern recognition receptor signaling pathway | 1.40e-03 | 294 | 16 | 3 | GO:0002221 | |
| GeneOntologyBiologicalProcess | regulation of vesicle-mediated transport | 1.45e-03 | 667 | 16 | 4 | GO:0060627 | |
| GeneOntologyBiologicalProcess | mast cell degranulation | 1.47e-03 | 74 | 16 | 2 | GO:0043303 | |
| GeneOntologyBiologicalProcess | regulation of cell morphogenesis | 1.51e-03 | 302 | 16 | 3 | GO:0022604 | |
| GeneOntologyBiologicalProcess | somitogenesis | 1.55e-03 | 76 | 16 | 2 | GO:0001756 | |
| GeneOntologyBiologicalProcess | mast cell mediated immunity | 1.55e-03 | 76 | 16 | 2 | GO:0002448 | |
| GeneOntologyBiologicalProcess | regulation of kinase activity | 1.60e-03 | 686 | 16 | 4 | GO:0043549 | |
| GeneOntologyBiologicalProcess | mast cell activation involved in immune response | 1.64e-03 | 78 | 16 | 2 | GO:0002279 | |
| GeneOntologyBiologicalProcess | cell morphogenesis | 1.65e-03 | 1194 | 16 | 5 | GO:0000902 | |
| GeneOntologyBiologicalProcess | innate immune response-activating signaling pathway | 1.66e-03 | 312 | 16 | 3 | GO:0002758 | |
| GeneOntologyBiologicalProcess | myeloid leukocyte activation | 1.78e-03 | 320 | 16 | 3 | GO:0002274 | |
| GeneOntologyBiologicalProcess | peptidyl-tyrosine phosphorylation | 1.90e-03 | 327 | 16 | 3 | GO:0018108 | |
| GeneOntologyBiologicalProcess | peptidyl-tyrosine modification | 1.93e-03 | 329 | 16 | 3 | GO:0018212 | |
| GeneOntologyBiologicalProcess | positive regulation of protein phosphorylation | 1.96e-03 | 724 | 16 | 4 | GO:0001934 | |
| GeneOntologyBiologicalProcess | positive regulation of immune system process | 1.96e-03 | 1242 | 16 | 5 | GO:0002684 | |
| GeneOntologyBiologicalProcess | activation of innate immune response | 2.00e-03 | 333 | 16 | 3 | GO:0002218 | |
| GeneOntologyBiologicalProcess | glial cell proliferation | 2.03e-03 | 87 | 16 | 2 | GO:0014009 | |
| GeneOntologyBiologicalProcess | B cell activation | 2.14e-03 | 341 | 16 | 3 | GO:0042113 | |
| GeneOntologyBiologicalProcess | negative regulation of cell development | 2.36e-03 | 353 | 16 | 3 | GO:0010721 | |
| GeneOntologyBiologicalProcess | somite development | 2.37e-03 | 94 | 16 | 2 | GO:0061053 | |
| GeneOntologyBiologicalProcess | regulation of protein serine/threonine kinase activity | 2.45e-03 | 358 | 16 | 3 | GO:0071900 | |
| GeneOntologyBiologicalProcess | positive regulation of phosphorylation | 2.57e-03 | 780 | 16 | 4 | GO:0042327 | |
| GeneOntologyBiologicalProcess | negative regulation of protein phosphorylation | 2.80e-03 | 375 | 16 | 3 | GO:0001933 | |
| GeneOntologyBiologicalProcess | steroid metabolic process | 2.82e-03 | 376 | 16 | 3 | GO:0008202 | |
| GeneOntologyBiologicalProcess | regulation of transferase activity | 2.94e-03 | 810 | 16 | 4 | GO:0051338 | |
| HumanPheno | Leukocytosis | 2.97e-05 | 159 | 7 | 4 | HP:0001974 | |
| HumanPheno | Elevated circulating C-reactive protein concentration | 1.30e-04 | 81 | 7 | 3 | HP:0011227 | |
| HumanPheno | Abnormal circulating C-reactive protein concentration | 1.44e-04 | 84 | 7 | 3 | HP:0032436 | |
| MousePheno | abnormal bile duct epithelium morphology | 5.58e-06 | 4 | 14 | 2 | MP:0013611 | |
| MousePheno | small cecum | 9.30e-06 | 5 | 14 | 2 | MP:0009477 | |
| MousePheno | abnormal small intestinal crypt cell physiology | 5.10e-05 | 11 | 14 | 2 | MP:0010156 | |
| MousePheno | increased mast cell number | 6.11e-05 | 12 | 14 | 2 | MP:0000324 | |
| MousePheno | peritoneal inflammation | 6.11e-05 | 12 | 14 | 2 | MP:0003303 | |
| MousePheno | spleen hyperplasia | 7.52e-05 | 85 | 14 | 3 | MP:0000693 | |
| MousePheno | intestinal obstruction | 8.42e-05 | 14 | 14 | 2 | MP:0003270 | |
| MousePheno | abnormal level of surface class II molecules | 1.93e-04 | 21 | 14 | 2 | MP:0005042 | |
| MousePheno | abnormal digestive system physiology | 2.06e-04 | 599 | 14 | 5 | MP:0001663 | |
| MousePheno | spleen hypoplasia | 2.54e-04 | 128 | 14 | 3 | MP:0000694 | |
| MousePheno | abnormal antigen presentation via MHC class II | 2.54e-04 | 24 | 14 | 2 | MP:0005041 | |
| MousePheno | abnormal complement pathway | 2.99e-04 | 26 | 14 | 2 | MP:0002471 | |
| MousePheno | abnormal mast cell number | 3.22e-04 | 27 | 14 | 2 | MP:0020203 | |
| MousePheno | hyperpigmentation | 3.47e-04 | 28 | 14 | 2 | MP:0001188 | |
| MousePheno | small Peyer's patches | 3.47e-04 | 28 | 14 | 2 | MP:0008135 | |
| MousePheno | increased urine protein level | 3.96e-04 | 149 | 14 | 3 | MP:0002962 | |
| MousePheno | gastrointestinal ulcer | 4.26e-04 | 31 | 14 | 2 | MP:0003300 | |
| MousePheno | decreased litter size | 4.33e-04 | 380 | 14 | 4 | MP:0001935 | |
| MousePheno | decreased epididymis weight | 4.83e-04 | 33 | 14 | 2 | MP:0004929 | |
| MousePheno | abnormal ileum morphology | 4.83e-04 | 33 | 14 | 2 | MP:0002581 | |
| MousePheno | decreased spleen white pulp amount | 5.13e-04 | 34 | 14 | 2 | MP:0008479 | |
| MousePheno | myeloid hyperplasia | 5.13e-04 | 34 | 14 | 2 | MP:0010373 | |
| MousePheno | abnormal litter size | 5.21e-04 | 399 | 14 | 4 | MP:0001933 | |
| MousePheno | abnormal Peyer's patch size | 5.75e-04 | 36 | 14 | 2 | MP:0008134 | |
| MousePheno | abnormal urine protein level | 5.83e-04 | 170 | 14 | 3 | MP:0006315 | |
| MousePheno | abnormal tumor pathology | 6.45e-04 | 176 | 14 | 3 | MP:0010639 | |
| MousePheno | abnormal nephron morphology | 6.68e-04 | 426 | 14 | 4 | MP:0003881 | |
| MousePheno | abnormal hepatobiliary system physiology | 7.10e-04 | 433 | 14 | 4 | MP:0002139 | |
| MousePheno | impaired humoral immune response | 7.11e-04 | 40 | 14 | 2 | MP:0020154 | |
| MousePheno | increased plasma cell number | 7.11e-04 | 40 | 14 | 2 | MP:0008097 | |
| MousePheno | abnormal epididymis weight | 7.84e-04 | 42 | 14 | 2 | MP:0004927 | |
| MousePheno | abnormal mast cell morphology | 7.84e-04 | 42 | 14 | 2 | MP:0000359 | |
| MousePheno | abnormal granulocyte number | 8.09e-04 | 805 | 14 | 5 | MP:0020201 | |
| MousePheno | increased erythroid progenitor cell number | 9.00e-04 | 45 | 14 | 2 | MP:0003135 | |
| MousePheno | arrested B cell differentiation | 9.40e-04 | 46 | 14 | 2 | MP:0001802 | |
| MousePheno | abnormal granulocyte morphology | 9.56e-04 | 835 | 14 | 5 | MP:0002441 | |
| MousePheno | abnormal gastrointestinal motility | 1.20e-03 | 52 | 14 | 2 | MP:0011082 | |
| MousePheno | abnormal neutrophil cell number | 1.21e-03 | 499 | 14 | 4 | MP:0012440 | |
| MousePheno | abnormal neutrophil morphology | 1.32e-03 | 511 | 14 | 4 | MP:0005065 | |
| MousePheno | abnormal large intestine crypts of Lieberkuhn morphology | 1.34e-03 | 55 | 14 | 2 | MP:0004842 | |
| MousePheno | decreased circulating HDL cholesterol level | 1.40e-03 | 230 | 14 | 3 | MP:0000186 | |
| MousePheno | increased B-1 B cell number | 1.54e-03 | 59 | 14 | 2 | MP:0004977 | |
| MousePheno | abnormal plasma cell number | 1.54e-03 | 59 | 14 | 2 | MP:0008096 | |
| MousePheno | increased dendritic cell number | 1.59e-03 | 60 | 14 | 2 | MP:0008126 | |
| MousePheno | abnormal bile duct morphology | 1.81e-03 | 64 | 14 | 2 | MP:0002928 | |
| MousePheno | abnormal response to transplant | 1.81e-03 | 64 | 14 | 2 | MP:0005671 | |
| MousePheno | decreased granulocyte number | 1.86e-03 | 254 | 14 | 3 | MP:0000334 | |
| MousePheno | distended abdomen | 1.87e-03 | 65 | 14 | 2 | MP:0001270 | |
| MousePheno | glomerulosclerosis | 2.04e-03 | 68 | 14 | 2 | MP:0005264 | |
| MousePheno | abnormal renal glomerulus morphology | 2.08e-03 | 264 | 14 | 3 | MP:0005325 | |
| MousePheno | small epididymis | 2.16e-03 | 70 | 14 | 2 | MP:0004930 | |
| MousePheno | increased B cell number | 2.24e-03 | 271 | 14 | 3 | MP:0005014 | |
| MousePheno | abnormal antigen presentation | 2.29e-03 | 72 | 14 | 2 | MP:0001835 | |
| MousePheno | decreased circulating triglyceride level | 2.33e-03 | 275 | 14 | 3 | MP:0002644 | |
| MousePheno | increased granulocyte number | 2.34e-03 | 597 | 14 | 4 | MP:0000322 | |
| MousePheno | abnormal large intestine morphology | 2.36e-03 | 276 | 14 | 3 | MP:0000489 | |
| MousePheno | abnormal sexual maturation | 2.41e-03 | 74 | 14 | 2 | MP:0001937 | |
| MousePheno | abnormal proerythroblast morphology | 2.41e-03 | 74 | 14 | 2 | MP:0002416 | |
| MousePheno | abnormal plasma cell morphology | 2.48e-03 | 75 | 14 | 2 | MP:0002439 | |
| MousePheno | abnormal intestinal epithelium physiology | 2.54e-03 | 76 | 14 | 2 | MP:0014201 | |
| MousePheno | abnormal B cell differentiation | 2.64e-03 | 287 | 14 | 3 | MP:0002144 | |
| MousePheno | abnormal renal corpuscle morphology | 2.79e-03 | 293 | 14 | 3 | MP:0002827 | |
| MousePheno | decreased B-1 B cell number | 2.88e-03 | 81 | 14 | 2 | MP:0004978 | |
| MousePheno | abnormal class switch recombination | 2.88e-03 | 81 | 14 | 2 | MP:0004816 | |
| MousePheno | abnormal hematopoietic precursor cell morphology | 2.96e-03 | 299 | 14 | 3 | MP:0013707 | |
| Domain | ABC_TRANSPORTER_2 | 8.58e-04 | 48 | 17 | 2 | PS50893 | |
| Domain | ABC_tran | 8.58e-04 | 48 | 17 | 2 | PF00005 | |
| Domain | ABC_TRANSPORTER_1 | 8.94e-04 | 49 | 17 | 2 | PS00211 | |
| Domain | ABC_transporter-like | 9.31e-04 | 50 | 17 | 2 | IPR003439 | |
| Domain | TyrKc | 2.85e-03 | 88 | 17 | 2 | SM00219 | |
| Domain | Tyr_kinase_cat_dom | 2.85e-03 | 88 | 17 | 2 | IPR020635 | |
| Domain | PROTEIN_KINASE_TYR | 3.45e-03 | 97 | 17 | 2 | PS00109 | |
| Domain | Tyr_kinase_AS | 3.45e-03 | 97 | 17 | 2 | IPR008266 | |
| Domain | Pkinase_Tyr | 6.02e-03 | 129 | 17 | 2 | PF07714 | |
| Domain | Ser-Thr/Tyr_kinase_cat_dom | 6.85e-03 | 138 | 17 | 2 | IPR001245 | |
| Domain | AAA+_ATPase | 7.44e-03 | 144 | 17 | 2 | IPR003593 | |
| Domain | AAA | 7.44e-03 | 144 | 17 | 2 | SM00382 | |
| Domain | Kinase-like_dom | 1.22e-02 | 542 | 17 | 3 | IPR011009 | |
| Pathway | REACTOME_REGULATION_OF_KIT_SIGNALING | 5.15e-05 | 13 | 12 | 2 | MM14565 | |
| Pathway | REACTOME_REGULATION_OF_KIT_SIGNALING | 7.92e-05 | 16 | 12 | 2 | M537 | |
| Pathway | REACTOME_SIGNALING_BY_KIT_IN_DISEASE | 1.25e-04 | 20 | 12 | 2 | M39002 | |
| Pathway | REACTOME_SIGNALING_BY_SCF_KIT | 4.35e-04 | 37 | 12 | 2 | MM14564 | |
| Pathway | REACTOME_SIGNALING_BY_SCF_KIT | 5.88e-04 | 43 | 12 | 2 | M508 | |
| Pathway | KEGG_ABC_TRANSPORTERS | 6.16e-04 | 44 | 12 | 2 | M11911 | |
| Pathway | PID_KIT_PATHWAY | 8.60e-04 | 52 | 12 | 2 | M231 | |
| Pubmed | 5.42e-09 | 8 | 17 | 3 | 23896410 | ||
| Pubmed | 2.25e-07 | 2 | 17 | 2 | 19100679 | ||
| Pubmed | 2.25e-07 | 2 | 17 | 2 | 9341198 | ||
| Pubmed | Regulation of DNA-dependent protein kinase by the Lyn tyrosine kinase. | 2.25e-07 | 2 | 17 | 2 | 9748231 | |
| Pubmed | Mast cells decrease efficacy of anti-angiogenic therapy by secreting matrix-degrading granzyme B. | 6.74e-07 | 3 | 17 | 2 | 28814715 | |
| Pubmed | Kit regulates HSC engraftment across the human-mouse species barrier. | 6.74e-07 | 3 | 17 | 2 | 25017720 | |
| Pubmed | 6.74e-07 | 3 | 17 | 2 | 38579682 | ||
| Pubmed | Basophils and the T helper 2 environment can promote the development of lupus nephritis. | 6.74e-07 | 3 | 17 | 2 | 20512127 | |
| Pubmed | 6.74e-07 | 3 | 17 | 2 | 25601207 | ||
| Pubmed | 6.74e-07 | 3 | 17 | 2 | 21971708 | ||
| Pubmed | Small-Molecule PAPD5 Inhibitors Restore Telomerase Activity in Patient Stem Cells. | 6.74e-07 | 3 | 17 | 2 | 32320679 | |
| Pubmed | Human KIT+ myeloid cells facilitate visceral metastasis by melanoma. | 6.74e-07 | 3 | 17 | 2 | 33857287 | |
| Pubmed | 6.74e-07 | 3 | 17 | 2 | 23246483 | ||
| Pubmed | A mast cell-ILC2-Th9 pathway promotes lung inflammation in cystic fibrosis. | 6.74e-07 | 3 | 17 | 2 | 28090087 | |
| Pubmed | 1.35e-06 | 4 | 17 | 2 | 32814027 | ||
| Pubmed | 1.35e-06 | 4 | 17 | 2 | 36944331 | ||
| Pubmed | Btk plays a crucial role in the amplification of Fc epsilonRI-mediated mast cell activation by kit. | 1.35e-06 | 4 | 17 | 2 | 16176929 | |
| Pubmed | 1.35e-06 | 4 | 17 | 2 | 29915289 | ||
| Pubmed | IL-9 and Mast Cells Are Key Players of Candida albicans Commensalism and Pathogenesis in the Gut. | 1.35e-06 | 4 | 17 | 2 | 29742432 | |
| Pubmed | Mobilization-based chemotherapy-free engraftment of gene-edited human hematopoietic stem cells. | 1.35e-06 | 4 | 17 | 2 | 35617958 | |
| Pubmed | BRD9 regulates normal human hematopoietic stem cell function and lineage differentiation. | 1.35e-06 | 4 | 17 | 2 | 38816579 | |
| Pubmed | 1.35e-06 | 4 | 17 | 2 | 32589703 | ||
| Pubmed | 2.25e-06 | 5 | 17 | 2 | 11825908 | ||
| Pubmed | 2.25e-06 | 5 | 17 | 2 | 19362019 | ||
| Pubmed | 2.25e-06 | 5 | 17 | 2 | 28822039 | ||
| Pubmed | 3.37e-06 | 6 | 17 | 2 | 9799234 | ||
| Pubmed | 3.37e-06 | 6 | 17 | 2 | 1381360 | ||
| Pubmed | 6.29e-06 | 8 | 17 | 2 | 3297105 | ||
| Pubmed | Gab2 is involved in differential phosphoinositide 3-kinase signaling by two splice forms of c-Kit. | 8.08e-06 | 9 | 17 | 2 | 18697750 | |
| Pubmed | Isolation and chromosomal location of Nsk1, a novel murine putative receptor tyrosine kinase. | 1.01e-05 | 10 | 17 | 2 | 8535092 | |
| Pubmed | Molecular cloning of the mouse APS as a member of the Lnk family adaptor proteins. | 1.48e-05 | 12 | 17 | 2 | 10872802 | |
| Pubmed | 1.75e-05 | 13 | 17 | 2 | 22724066 | ||
| Pubmed | 2.69e-05 | 16 | 17 | 2 | 11071635 | ||
| Pubmed | Comparative analysis of 1196 orthologous mouse and human full-length mRNA and protein sequences. | 6.70e-05 | 25 | 17 | 2 | 8889551 | |
| Pubmed | 8.44e-05 | 28 | 17 | 2 | 28218627 | ||
| Pubmed | Murine txk: a protein tyrosine kinase gene regulated by T cell activation. | 1.11e-04 | 32 | 17 | 2 | 7542761 | |
| Pubmed | 1.37e-04 | 209 | 17 | 3 | 36779422 | ||
| Pubmed | The Functional Proximal Proteome of Oncogenic Ras Includes mTORC2. | 1.42e-04 | 569 | 17 | 4 | 30639242 | |
| Pubmed | 1.65e-04 | 39 | 17 | 2 | 24709693 | ||
| Pubmed | Activated Braf induces esophageal dilation and gastric epithelial hyperplasia in mice. | 2.20e-04 | 45 | 17 | 2 | 28973166 | |
| Pubmed | 3.29e-04 | 55 | 17 | 2 | 34237211 | ||
| Pubmed | Genetic mutations associated with cigarette smoking in pancreatic cancer. | 4.32e-04 | 63 | 17 | 2 | 19351817 | |
| Interaction | LPCAT1 interactions | 2.75e-06 | 129 | 16 | 4 | int:LPCAT1 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr7p12 | 2.49e-04 | 63 | 17 | 2 | chr7p12 | |
| ToppCell | Smart-seq2-lymph_node_(Smart-seq2)-myeloid-myeloid_granulocytic|lymph_node_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 2.48e-05 | 152 | 17 | 3 | 32634195048858ae84605c61e43c542d90f7cab5 | |
| ToppCell | Smart-seq2-lymph_node_(Smart-seq2)-myeloid-myeloid_granulocytic-mast_cell|lymph_node_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 2.48e-05 | 152 | 17 | 3 | 0eb185b2404f015efff1bd140e0c502d714720fb | |
| ToppCell | droplet-Spleen-nan-18m-Myeloid-granulocyte|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.06e-05 | 163 | 17 | 3 | bc37c5d9f48b16096d5313657563f3ec84028c8c | |
| ToppCell | NS-control-d_0-4-Epithelial-Ionocyte|d_0-4 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 3.23e-05 | 166 | 17 | 3 | 6d9fb239f69ba519844f593c00d515e1aac4ff50 | |
| ToppCell | NS-critical-d_16-33-Epithelial-Ionocyte|d_16-33 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 3.35e-05 | 168 | 17 | 3 | 6a233045638cb83dab64789b996b7598c325001e | |
| ToppCell | Bronchial_Biopsy-Epithelial-Ionocytes|Bronchial_Biopsy / Tissue, Lineage and Cell class of Lung Cells from 10X | 3.71e-05 | 174 | 17 | 3 | 7e7b13de916cd4fa0fa6fb06e6b4942877afa9fb | |
| ToppCell | Bronchial_Biopsy-Epithelial-Ionocytes|Epithelial / Tissue, Lineage and Cell class of Lung Cells from 10X | 3.78e-05 | 175 | 17 | 3 | 13b8f7dc38c90b74d4a20a84a8705d8e2ec244f6 | |
| ToppCell | 3'_v3-blood-Mast-Mast_cells|blood / Manually curated celltypes from each tissue | 3.84e-05 | 176 | 17 | 3 | b9da3deaf62622d47eb30b6be7548253eee95597 | |
| ToppCell | 3'-Airway_Nasal-Epithelial-Neuro-endocrine/ionocytic-ionocyte-Ionocyte|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.91e-05 | 177 | 17 | 3 | 6d89042bda8e244babb68929e84b25edcb545a77 | |
| ToppCell | 3'-Airway_Nasal-Epithelial-Neuro-endocrine/ionocytic-ionocyte-Ionocyte-Ionocyte_L.0.7.0.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.91e-05 | 177 | 17 | 3 | daaccf1249dcf816df4caca695a944f53078291a | |
| ToppCell | 3'-Airway_Nasal-Epithelial-Neuro-endocrine/ionocytic|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.91e-05 | 177 | 17 | 3 | c5a16f984c836dbf7d0faf061677844167ab612a | |
| ToppCell | 3'-Airway_Nasal-Epithelial-Neuro-endocrine/ionocytic-ionocyte|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.91e-05 | 177 | 17 | 3 | 338bdda26796bf4e16072878c070212d1006cf57 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_intercalated_cell-Cortical_Collecting_Duct_Intercalated_Cell_Type_A|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 4.04e-05 | 179 | 17 | 3 | e6ae070b4c52ba08167c7d64ea4cfbac0454c1bf | |
| ToppCell | E16.5-samps-Endothelial-Immature_fetal_endothelial-Proliferative_Endothelial|E16.5-samps / Age Group, Lineage, Cell class and subclass | 4.04e-05 | 179 | 17 | 3 | d24513a404c9b1d37dd47aa1cdb5713b64b88f89 | |
| ToppCell | NS-moderate-d_16-33-Epithelial-Ionocyte|d_16-33 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 4.11e-05 | 180 | 17 | 3 | 8af8b4af2dc72223ac71fc027e0d4280c5dd81f8 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_intercalated_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 4.18e-05 | 181 | 17 | 3 | 30729f0364f719c044712a51453e22dc2c1a232b | |
| ToppCell | NS-critical-d_07-13-Epithelial-Ionocyte|d_07-13 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 4.32e-05 | 183 | 17 | 3 | ba43bca2b45be1008eebd3f033cecb061fb3a966 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.39e-05 | 184 | 17 | 3 | ea7a7e2bac46d4d2c31a5d576b38a032b5335062 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.39e-05 | 184 | 17 | 3 | 2cbed6462fea2622871bb7e49b0df3d984239281 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.39e-05 | 184 | 17 | 3 | 2b19a8c5f823e00812908b23e66bb4e563278aff | |
| ToppCell | critical-Epithelial-Ionocyte|critical / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 4.39e-05 | 184 | 17 | 3 | 58d36577eff814d46d72f031f3533d71549e3d6e | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_intercalated_cell-Degenerative_Cortical_Intercalated_Cell_Type_A|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 4.46e-05 | 185 | 17 | 3 | 9438097e94219c1db922b8507e3a29106d32a923 | |
| ToppCell | moderate-Epithelial-Ionocyte|moderate / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 4.60e-05 | 187 | 17 | 3 | 3e3fe2d5712a0ac477cddefe56705d4b8d8f7eac | |
| ToppCell | moderate-Epithelial-Ionocyte|Epithelial / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 4.75e-05 | 189 | 17 | 3 | 6011b747e27d61d222380a7bffdd921a68e9b657 | |
| ToppCell | droplet-Lung-nan-18m-Epithelial|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.83e-05 | 190 | 17 | 3 | b057bea6e55cef872290893b6e439bbcdcee2f2e | |
| ToppCell | droplet-Lung-immune-endo-depleted-3m-Epithelial|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.83e-05 | 190 | 17 | 3 | edc0a0eb17abbecb0f06d302be3d4f8c1dd4f333 | |
| ToppCell | COPD-Myeloid-Mast|Myeloid / Disease state, Lineage and Cell class | 4.83e-05 | 190 | 17 | 3 | 379dbac19110b76079a7a53209569e060a852acb | |
| ToppCell | facs-Mammary_Gland-Mammary_Gland-18m-Epithelial-luminal_epithelial_cell_of_mammary_gland|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.06e-05 | 193 | 17 | 3 | 1526f51b589a7dc7a28f35f0e788dc38d338d2bc | |
| ToppCell | Tracheal-10x5prime-Epithelial-Epi_airway_neuro-secretory|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 5.29e-05 | 196 | 17 | 3 | a4cc02ea41479d24044bd2ca6441f85d683c0ca9 | |
| ToppCell | Tracheal-NucSeq-Epithelial-Epi_airway_secretory|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 5.29e-05 | 196 | 17 | 3 | b07db4a53ab9be9aad6fae5e45f9547db829d096 | |
| ToppCell | Tracheal-10x5prime-Epithelial-Epi_airway_neuro-secretory-Ionocyte_n_Brush|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 5.29e-05 | 196 | 17 | 3 | 50aaca81b593ff71790bb75403b2e4c3ab03a6d2 | |
| ToppCell | Tracheal-NucSeq-Epithelial-Epi_airway_secretory-Secretory_Goblet|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 5.29e-05 | 196 | 17 | 3 | c366f980cc04abfe1c0c14746c11810c812a42c0 | |
| ToppCell | Bronchus_Control_(B.)-Epithelial-TX-AT1|Bronchus_Control_(B.) / Sample group, Lineage and Cell type | 5.37e-05 | 197 | 17 | 3 | f7ef62d78336812573148f8bfce401877ec4e29c | |
| ToppCell | Posterior_cortex-Neuronal-Inhibitory-iN2(Gad1Gad2)-Cplx3-Inhibitory_Neuron.Gad1Gad2.Cplx3-Egln3_(Cortical_subplate_interneuron)|Posterior_cortex / BrainAtlas - Mouse McCarroll V32 | 1.83e-04 | 53 | 17 | 2 | 52a1f2a041e3ba2b11ed753f2f57b78e68b5cc0c | |
| ToppCell | Posterior_cortex-Neuronal-Inhibitory-iN2(Gad1Gad2)-Cplx3-Inhibitory_Neuron.Gad1Gad2.Cplx3-Egln3_(Cortical_subplate_interneuron)-|Posterior_cortex / BrainAtlas - Mouse McCarroll V32 | 1.83e-04 | 53 | 17 | 2 | 5fa009c9f30c77de6cece40a47da46241f1de54c | |
| ToppCell | 368C-Lymphocytic-NK_cells-NK_cell_E|NK_cells / Donor, Lineage, Cell class and subclass (all cells) | 5.05e-04 | 88 | 17 | 2 | 142d2e00ef19c0ad011a21945bf1111271056eae | |
| ToppCell | Parenchymal-10x5prime-Epithelial-Epi_submucosal-gland|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 7.58e-04 | 108 | 17 | 2 | 75d635fc5bb004418db2e1328c24d96b718f10b1 | |
| ToppCell | Parenchymal-10x5prime-Epithelial-Epi_submucosal-gland-SMG_Duct|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 7.58e-04 | 108 | 17 | 2 | 9c7f3e25facfb54ef0be45044999bc36438bbea0 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_intercalated_cell-Outer_Medullary_Collecting_Duct_Intercalated_Cell_Type_A|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 9.97e-04 | 124 | 17 | 2 | 1fec6663cea40017438ead397b3bf8b3cdb67e58 | |
| ToppCell | Entopeduncular-Macroglia-ASTROCYTE|Entopeduncular / BrainAtlas - Mouse McCarroll V32 | 1.08e-03 | 129 | 17 | 2 | c37bdd6c0b2944fbfa064922954ea0e263160e2a | |
| ToppCell | Entopeduncular-Macroglia-ASTROCYTE-Gja1|Entopeduncular / BrainAtlas - Mouse McCarroll V32 | 1.08e-03 | 129 | 17 | 2 | 8648ae59f7aca0f5b4983bdb4a65b03b2ca761e1 | |
| ToppCell | frontal_cortex-Neuronal-GABAergic_neuron-Vip-Vip_Col15a1_Pde1a|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 1.10e-03 | 130 | 17 | 2 | 56b9c3325e011f1dbaf9efc71bd6e1af4f96fda6 | |
| ToppCell | LPS-IL1RA+antiTNF-Hematopoietic_Mast-Mast_cells-Mast-cells|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.15e-03 | 133 | 17 | 2 | 81189e8516a431d5890a0909f9fc7c82ec3442bc | |
| ToppCell | primary_visual_cortex-Neuronal-GABAergic_neuron-Vip-Vip_Col15a1_Pde1a|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 1.16e-03 | 134 | 17 | 2 | d63fff23040eada31bc35ba1e05b7c6a663e0037 | |
| ToppCell | (09)_Ionocytes|World / shred by cell type and Timepoint | 1.18e-03 | 135 | 17 | 2 | 237b9b646513ca6e4b754c0da95d24015b3661f7 | |
| ToppCell | 10x_3'_v3-blood_(10x_3'_v3)-hematologic-hematopoietic_progenitor-common_myeloid_progenitor|blood_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 1.21e-03 | 137 | 17 | 2 | 6d90da42dcc06aa895f920218055068f3c76d57d | |
| ToppCell | TCGA-Kidney-Primary_Tumor-Renal_Cell_Carcinoma-Kidney_Chromophobe-9|TCGA-Kidney / Sample_Type by Project: Shred V9 | 1.25e-03 | 139 | 17 | 2 | a93b861906d7f01ff715084f99152ec83529f8b3 | |
| ToppCell | TCGA-Kidney-Primary_Tumor-Renal_Cell_Carcinoma-Kidney_Chromophobe|TCGA-Kidney / Sample_Type by Project: Shred V9 | 1.27e-03 | 140 | 17 | 2 | bc5bed94c33129391ca35791febb55cc4cdff989 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_intercalated_cell-Connecting_Tubule_Intercalated_Cell_Type_A|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.36e-03 | 145 | 17 | 2 | 9964d6d3769be2f35d86268fe044cecd1d5a1616 | |
| ToppCell | frontal_cortex-Neuronal-GABAergic_neuron-Vip-Vip_Crispld2_Htr2c|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 1.38e-03 | 146 | 17 | 2 | 47368f981180ca6a8c81a50f7f9430f12456f609 | |
| ToppCell | P15-Epithelial-epithelial_progenitor_cell-epithelial_progenitor_cell|P15 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 1.40e-03 | 147 | 17 | 2 | aba44c7057096483c4293a7ebcf8ccc8baed0231 | |
| ToppCell | 356C-Myeloid-Mast_cell|356C / Donor, Lineage, Cell class and subclass (all cells) | 1.42e-03 | 148 | 17 | 2 | 1668d8a9e680da335362744f36b05446c499347e | |
| ToppCell | 356C-Myeloid-Mast_cell-|356C / Donor, Lineage, Cell class and subclass (all cells) | 1.42e-03 | 148 | 17 | 2 | 18511ba10765eda937c5a710626361f7e6b9b321 | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_intercalated_cell-Cortical_Collecting_Duct_Intercalated_Cell_Type_A|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.43e-03 | 149 | 17 | 2 | cc911b454fe4e4b489885b9920baa7eb01a027ba | |
| ToppCell | facs-Liver-Liver_non-hepato/SCs_st-18m-Myeloid-neutrophil|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.45e-03 | 150 | 17 | 2 | 6e806a028c0519489151c181d9907e05289e27e0 | |
| ToppCell | 368C-Myeloid-Mast_cell|368C / Donor, Lineage, Cell class and subclass (all cells) | 1.49e-03 | 152 | 17 | 2 | faf30245a1690aaa27c7be0832797c340e4af4d7 | |
| ToppCell | 368C-Myeloid-Mast_cell-|368C / Donor, Lineage, Cell class and subclass (all cells) | 1.49e-03 | 152 | 17 | 2 | 519c9ed05fdaf420e42147ffae1dc05a7f86fdd4 | |
| ToppCell | TCGA-Thymus-Primary_Tumor-Thymoma-Type_C-8|TCGA-Thymus / Sample_Type by Project: Shred V9 | 1.55e-03 | 155 | 17 | 2 | 00eef9f93a753a1fe1ab5fd8dae026e7be556cde | |
| ToppCell | droplet-Kidney-KIDNEY-30m-Myeloid-nan|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.57e-03 | 156 | 17 | 2 | 6e60e860603a7e8194f437a574ff8e887f6083b8 | |
| ToppCell | facs-Spleen-nan-24m-Myeloid|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.57e-03 | 156 | 17 | 2 | 034d4359359a44c205c6931f38a375271ac2752b | |
| ToppCell | COVID-19-Mast_cells|COVID-19 / group, cell type (main and fine annotations) | 1.57e-03 | 156 | 17 | 2 | 159504d43421ee83b9ab484816333ae549c9c2fd | |
| ToppCell | facs-Spleen-nan-24m-Myeloid-nan|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.57e-03 | 156 | 17 | 2 | 2a4dac4100c0339aad4905b8eaca6e8fe806718b | |
| ToppCell | facs-Spleen-nan-24m-Myeloid-granulocyte|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.57e-03 | 156 | 17 | 2 | 21267718d3a3dc19988663b6846aed8bb3eae836 | |
| ToppCell | droplet-Limb_Muscle-MUSCLE-30m-Myeloid-macrophage|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.57e-03 | 156 | 17 | 2 | c841faa1695ff577b0774f531adf1343d05dce9e | |
| ToppCell | frontal_cortex-Neuronal-GABAergic_neuron-Vip-Vip_Crispld2_Kcne4|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 1.57e-03 | 156 | 17 | 2 | 896e2d958be0a5c62fb6eebad2dfb7e1ce69f3ad | |
| ToppCell | COVID-19-Mast_cells-Mast_cells|COVID-19 / group, cell type (main and fine annotations) | 1.57e-03 | 156 | 17 | 2 | bc10b94673184ef384c6665b16a1209a8975a4f1 | |
| ToppCell | droplet-Limb_Muscle-MUSCLE-30m-Myeloid|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.57e-03 | 156 | 17 | 2 | 21baf8c6e62bb7fd1530c2c100f73c0cecee092e | |
| ToppCell | facs-Trachea-24m-Hematologic-myeloid-granulocyte-granulocyte_l26|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.57e-03 | 156 | 17 | 2 | da5cfa8fa9595613f04ce9511f8b42bad34d995a | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_intercalated_cell-Cortical_Collecting_Duct_Intercalated_Cell_Type_A|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.59e-03 | 157 | 17 | 2 | c17c5c01fcb65c453690c265ec4f300ecdfefd34 | |
| ToppCell | facs-Heart-LV-24m-Lymphocytic-T_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.61e-03 | 158 | 17 | 2 | 12a82230c01de552f12977634c304626e1cd6903 | |
| ToppCell | LPS_only-Myeloid-Monocytes,_Macrophages-T-cells|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.61e-03 | 158 | 17 | 2 | 91d8c93af328c3bbebe1d8f019b94849ebc548c0 | |
| ToppCell | facs-Heart-LV-24m-Lymphocytic-T_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.61e-03 | 158 | 17 | 2 | bd432ecd2524656804e7c2775250e27db7906b70 | |
| ToppCell | IPF-Epithelial-Ionocyte|Epithelial / Disease state, Lineage and Cell class | 1.61e-03 | 158 | 17 | 2 | 67adf625a959444762d32268b3b7441f6f8b3b8c | |
| ToppCell | 10x_3'_v3-thymus_(10x_3'_v3)-myeloid-myeloid_granulocytic-mast_cell|thymus_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 1.63e-03 | 159 | 17 | 2 | ecd1daa33549541aee3bf4e139ab6732efc8e74c | |
| ToppCell | Frontal_cortex-Neuronal-Inhibitory-iN2(Gad1Gad2)|Frontal_cortex / BrainAtlas - Mouse McCarroll V32 | 1.63e-03 | 159 | 17 | 2 | 7f29f9dcf25ffa1822b137c571e9ac16defc6292 | |
| ToppCell | 10x_3'_v3-thymus_(10x_3'_v3)-myeloid-myeloid_granulocytic|thymus_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 1.63e-03 | 159 | 17 | 2 | 7b6370c9567da7d40541c6e243efa704ed7e90ae | |
| ToppCell | cellseq2-Epithelial-Epithelial_Neuro-Secretory-Ionocyte|cellseq2 / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.65e-03 | 160 | 17 | 2 | 9049707a4487f2337a17976ceb5fbd8815ab9e1d | |
| ToppCell | PND10-Immune-Immune_Myeloid-Granulocytic-Mast|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.65e-03 | 160 | 17 | 2 | 6393e3d5c5c8176c93aecd89b313bd054a00d474 | |
| ToppCell | cellseq2-Epithelial-Epithelial_Neuro-Secretory-Ionocyte-Ionocyte|cellseq2 / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.65e-03 | 160 | 17 | 2 | f2cfec54cf48a655f473b830be7d141c54b521ff | |
| ToppCell | PND10-Immune-Immune_Myeloid-Granulocytic-Mast-Mast_mature|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.65e-03 | 160 | 17 | 2 | 2065938e944eb99478fd8132c2c03adeaee6d447 | |
| ToppCell | NS-critical-LOC-Myeloid-Basophil|LOC / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 1.65e-03 | 160 | 17 | 2 | 8a4746463ca1976f7d6de803496c851249ced797 | |
| ToppCell | IPF-Epithelial-Ionocyte|IPF / Disease state, Lineage and Cell class | 1.65e-03 | 160 | 17 | 2 | d65d19f4fae60836bfd4303a1bb7de34e9d83e35 | |
| ToppCell | cellseq2-Epithelial-Epithelial_Neuro-Secretory|cellseq2 / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.65e-03 | 160 | 17 | 2 | 0eb50b3c494e1b65d40104b3b5411b57bb72b959 | |
| ToppCell | IPF-Epithelial-Ionocyte|World / Disease state, Lineage and Cell class | 1.67e-03 | 161 | 17 | 2 | f1cd5c938cdc08ad8995371b72493850a6cf277a | |
| ToppCell | Mild-MAIT|Mild / Disease group and Cell class | 1.67e-03 | 161 | 17 | 2 | 0c1a04485708d5302600cdc2d7dac1cb76b4033a | |
| ToppCell | primary_visual_cortex-Neuronal-GABAergic_neuron-Vip-Vip_Crispld2_Kcne4|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 1.67e-03 | 161 | 17 | 2 | be77e99faf653480c166305df3a4e93db76f0dcb | |
| ToppCell | 3'-Distal_airway-Epithelial-Neuro-endocrine/ionocytic-ionocyte-Ionocyte|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.69e-03 | 162 | 17 | 2 | 9522af31f6b2f3cb81b6b84bd08353eea504d1d6 | |
| ToppCell | 3'-Distal_airway-Epithelial-Neuro-endocrine/ionocytic-ionocyte|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.69e-03 | 162 | 17 | 2 | 9a18286e361e1dd18e6f943ce27db58b199fb6e4 | |
| ToppCell | 3'-Distal_airway-Epithelial-Neuro-endocrine/ionocytic|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.69e-03 | 162 | 17 | 2 | 40265af9b36fd144a8577b8dacccd4fc0888a593 | |
| ToppCell | Mild_COVID-19-Myeloid-MoAM2|Mild_COVID-19 / Disease group,lineage and cell class (2021.01.30) | 1.69e-03 | 162 | 17 | 2 | e5fc80ab19d513af6a7e677a5e67bfebca2e963b | |
| ToppCell | 3'-Distal_airway-Epithelial-Neuro-endocrine/ionocytic-ionocyte-Ionocyte-Ionocyte_L.0.7.0.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.69e-03 | 162 | 17 | 2 | 3395e4dffdb9304d157c325e1fc0f12b433c7bd3 | |
| ToppCell | E18.5-samps-Endothelial-Mature_fetal_endothelial-endothelial_cells_B|E18.5-samps / Age Group, Lineage, Cell class and subclass | 1.71e-03 | 163 | 17 | 2 | d6f9b7280c44d120df5a72dfc2ebb26ffbb5752b | |
| ToppCell | normal_Pleural_Fluid-Myeloid_cells-Undetermined|Myeloid_cells / Location, Cell class and cell subclass | 1.71e-03 | 163 | 17 | 2 | be774c0ba38fa89a9c0076524cf05d593c6c6826 | |
| ToppCell | TCGA-Thymus-Primary_Tumor-Thymoma-Type_C|TCGA-Thymus / Sample_Type by Project: Shred V9 | 1.71e-03 | 163 | 17 | 2 | 2dac87d15051151ccf193760ddd8b82534c3f922 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_intercalated_cell-Degenerative_Cortical_Intercalated_Cell_Type_A|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.73e-03 | 164 | 17 | 2 | 83141be8dfed85511ea6afda7c76ff4b6b5ef021 | |
| ToppCell | 356C-Myeloid-Mast_cell|Myeloid / Donor, Lineage, Cell class and subclass (all cells) | 1.73e-03 | 164 | 17 | 2 | b3192c443f4848e6a8afdb89c155f9ec42a154b0 | |
| ToppCell | NS-moderate-d_16-33-Myeloid-Mast_cell|d_16-33 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 1.73e-03 | 164 | 17 | 2 | 35c673380f75cb4bfe080089bc723c4373bcc7a5 | |
| ToppCell | Mild-MAIT|World / Disease group and Cell class | 1.73e-03 | 164 | 17 | 2 | 21dc02997dfae73cf70ce291661928526605dba1 | |
| ToppCell | 356C-Myeloid-Mast_cell-|Myeloid / Donor, Lineage, Cell class and subclass (all cells) | 1.73e-03 | 164 | 17 | 2 | f7288ec4daf494dae770ea6c58bead27660ccae1 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_intercalated_cell-Connecting_Tubule_Intercalated_Cell_Type_A|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.75e-03 | 165 | 17 | 2 | 9bd332e5ede759a00a47728ea5558c215efdd77a | |
| Computational | Neighborhood of SPINK1 | 3.95e-04 | 27 | 12 | 2 | GNF2_SPINK1 | |
| Drug | Megestrol acetate [595-33-5]; Up 200; 10.4uM; MCF7; HT_HG-U133A | 1.16e-05 | 196 | 17 | 4 | 6468_UP | |
| Drug | Esculetin [305-01-1]; Up 200; 22.4uM; MCF7; HT_HG-U133A | 1.18e-05 | 197 | 17 | 4 | 7459_UP | |
| Drug | Trapidil [15421-84-8]; Up 200; 19.4uM; MCF7; HT_HG-U133A | 1.21e-05 | 198 | 17 | 4 | 7475_UP | |
| Drug | (S)-(-)-Atenolol [93379-54-5]; Up 200; 15uM; MCF7; HT_HG-U133A | 1.23e-05 | 199 | 17 | 4 | 6444_UP | |
| Drug | quinazoline | 1.92e-05 | 71 | 17 | 3 | CID000009210 | |
| Drug | heptamolybdate | 7.49e-05 | 112 | 17 | 3 | CID005288823 | |
| Drug | Adenosine-5'-Diphosphate | 3.26e-04 | 36 | 17 | 2 | DB03431 | |
| Drug | Triflupromazine hydrochloride [1098-60-8]; Up 200; 10.2uM; MCF7; HT_HG-U133A | 3.46e-04 | 188 | 17 | 3 | 7466_UP | |
| Drug | Terfenadine [50679-08-8]; Down 200; 8.4uM; MCF7; HT_HG-U133A | 3.62e-04 | 191 | 17 | 3 | 2227_DN | |
| Drug | Estriol [50-27-1]; Down 200; 13.8uM; MCF7; HT_HG-U133A | 3.62e-04 | 191 | 17 | 3 | 7220_DN | |
| Drug | Dicumarol [66-76-2]; Up 200; 11.8uM; HL60; HT_HG-U133A | 3.68e-04 | 192 | 17 | 3 | 2561_UP | |
| Drug | Cefazolin sodium salt [27164-46-1]; Up 200; 8.4uM; PC3; HT_HG-U133A | 3.74e-04 | 193 | 17 | 3 | 7385_UP | |
| Drug | Iohexol [66108-95-0]; Up 200; 4.8uM; PC3; HT_HG-U133A | 3.79e-04 | 194 | 17 | 3 | 4643_UP | |
| Drug | Fluorometholone [426-13-1]; Up 200; 10.6uM; MCF7; HT_HG-U133A | 3.85e-04 | 195 | 17 | 3 | 6247_UP | |
| Drug | LY 294002; Down 200; 10uM; PC3; HT_HG-U133A | 3.85e-04 | 195 | 17 | 3 | 1239_DN | |
| Drug | Bacitracin [1405-87-4]; Up 200; 2.8uM; MCF7; HT_HG-U133A | 3.85e-04 | 195 | 17 | 3 | 7448_UP | |
| Drug | Furazolidone [67-45-8]; Down 200; 17.8uM; MCF7; HT_HG-U133A | 3.85e-04 | 195 | 17 | 3 | 3358_DN | |
| Drug | Crotamiton [483-63-6]; Down 200; 19.6uM; HL60; HT_HG-U133A | 3.85e-04 | 195 | 17 | 3 | 3050_DN | |
| Drug | Bambuterol hydrochloride [81732-46-9]; Up 200; 10uM; MCF7; HT_HG-U133A | 3.85e-04 | 195 | 17 | 3 | 3199_UP | |
| Drug | Imipramine hydrochloride [113-52-0]; Down 200; 12.6uM; MCF7; HT_HG-U133A | 3.91e-04 | 196 | 17 | 3 | 1685_DN | |
| Drug | Lactobionic acid [96-82-2]; Down 200; 11.2uM; PC3; HT_HG-U133A | 3.91e-04 | 196 | 17 | 3 | 6605_DN | |
| Drug | Aminohippuric acid [61-78-9]; Up 200; 20.6uM; MCF7; HT_HG-U133A | 3.91e-04 | 196 | 17 | 3 | 6453_UP | |
| Drug | Cinchonine [118-10-5]; Up 200; 13.6uM; HL60; HT_HG-U133A | 3.91e-04 | 196 | 17 | 3 | 2133_UP | |
| Drug | Clorsulon [60200-06-8]; Up 200; 10.6uM; MCF7; HT_HG-U133A | 3.91e-04 | 196 | 17 | 3 | 2884_UP | |
| Drug | Sulfacetamide sodic hydrate [6209-17-2]; Down 200; 15.8uM; MCF7; HT_HG-U133A | 3.91e-04 | 196 | 17 | 3 | 1695_DN | |
| Drug | Tremorine dihydrochloride [300-68-5]; Up 200; 15uM; MCF7; HT_HG-U133A | 3.91e-04 | 196 | 17 | 3 | 6273_UP | |
| Drug | Quipazine dimaleate salt [4774-24-7]; Up 200; 9uM; PC3; HT_HG-U133A | 3.97e-04 | 197 | 17 | 3 | 5887_UP | |
| Drug | Dydrogesterone [152-62-5]; Up 200; 12.8uM; HL60; HT_HG-U133A | 3.97e-04 | 197 | 17 | 3 | 2156_UP | |
| Drug | Chlorphensin carbamate [886-74-8]; Up 200; 16.2uM; MCF7; HT_HG-U133A | 3.97e-04 | 197 | 17 | 3 | 7472_UP | |
| Drug | Ascorbic acid [50-81-7]; Up 200; 22.4uM; PC3; HT_HG-U133A | 3.97e-04 | 197 | 17 | 3 | 6306_UP | |
| Drug | Clopamide [636-54-4]; Down 200; 11.6uM; MCF7; HT_HG-U133A | 3.97e-04 | 197 | 17 | 3 | 5402_DN | |
| Drug | Rauwolscine hydrochloride [6211-32-1]; Down 200; 10.2uM; PC3; HT_HG-U133A | 3.97e-04 | 197 | 17 | 3 | 5800_DN | |
| Drug | Trifluoperazine dihydrochloride [440-17-5]; Down 200; 8.4uM; HL60; HT_HG-U133A | 3.97e-04 | 197 | 17 | 3 | 2389_DN | |
| Drug | Dinoprost trometamol [38362-01-5]; Down 200; 8.4uM; MCF7; HT_HG-U133A | 3.97e-04 | 197 | 17 | 3 | 3308_DN | |
| Drug | Neomycin sulfate [1405-10-3]; Up 200; 4.2uM; MCF7; HT_HG-U133A | 3.97e-04 | 197 | 17 | 3 | 2229_UP | |
| Drug | Vigabatrin [60643-86-9]; Up 200; 31uM; PC3; HT_HG-U133A | 3.97e-04 | 197 | 17 | 3 | 6314_UP | |
| Drug | Suramin sodium salt; Up 200; 10uM; PC3; HT_HG-U133A | 3.97e-04 | 197 | 17 | 3 | 7529_UP | |
| Drug | prostaglandin E2; Up 200; 10uM; MCF7; HT_HG-U133A | 4.03e-04 | 198 | 17 | 3 | 6552_UP | |
| Drug | 16, 16-dimethylprostaglandin E2 methyl acetate solution; Up 200; 10uM; MCF7; HT_HG-U133A | 4.03e-04 | 198 | 17 | 3 | 6597_UP | |
| Drug | 5155877; Down 200; 10uM; PC3; HT_HG-U133A | 4.03e-04 | 198 | 17 | 3 | 6544_DN | |
| Drug | Altretamine [654-05-6]; Up 200; 19uM; MCF7; HT_HG-U133A | 4.03e-04 | 198 | 17 | 3 | 6467_UP | |
| Drug | Fluorocurarine chloride [22273-09-2]; Down 200; 11.6uM; MCF7; HT_HG-U133A | 4.03e-04 | 198 | 17 | 3 | 6083_DN | |
| Drug | Cyclizine hydrochloride [303-25-3]; Down 200; 13.2uM; HL60; HG-U133A | 4.03e-04 | 198 | 17 | 3 | 1731_DN | |
| Drug | Meclozine dihydrochloride [1104-22-9]; Up 200; 8.6uM; HL60; HT_HG-U133A | 4.03e-04 | 198 | 17 | 3 | 2424_UP | |
| Drug | Pirenperone [ 75444-65-4]; Down 200; 10.2uM; HL60; HT_HG-U133A | 4.03e-04 | 198 | 17 | 3 | 2455_DN | |
| Drug | Isoxicam [34552-84-6]; Up 200; 12uM; PC3; HT_HG-U133A | 4.03e-04 | 198 | 17 | 3 | 7268_UP | |
| Drug | Hydralazine hydrochloride [304-20-1]; Down 200; 20.4uM; PC3; HT_HG-U133A | 4.03e-04 | 198 | 17 | 3 | 4282_DN | |
| Drug | estradiol, USP; Up 200; 0.01uM; PC3; HT_HG-U133A | 4.03e-04 | 198 | 17 | 3 | 1241_UP | |
| Drug | Iopamidol [60166-93-0]; Down 200; 5.2uM; PC3; HT_HG-U133A | 4.09e-04 | 199 | 17 | 3 | 5832_DN | |
| Drug | ICI 182,780; Down 200; 1uM; PC3; HT_HG-U133A | 4.09e-04 | 199 | 17 | 3 | 1205_DN | |
| Drug | Iopanoic acid [96-83-3]; Up 200; 7uM; MCF7; HT_HG-U133A | 4.09e-04 | 199 | 17 | 3 | 5448_UP | |
| Drug | Meptazinol hydrochloride [59263-76-2]; Up 200; 14.8uM; MCF7; HT_HG-U133A | 4.09e-04 | 199 | 17 | 3 | 4774_UP | |
| Drug | Norethynodrel [68-23-5]; Down 200; 13.4uM; MCF7; HT_HG-U133A | 4.09e-04 | 199 | 17 | 3 | 7471_DN | |
| Drug | Coralyne chloride hydrate [38989-38-7]; Up 200; 9.6uM; PC3; HT_HG-U133A | 4.09e-04 | 199 | 17 | 3 | 6317_UP | |
| Drug | Ampicillin trihydrate [7177-48-2]; Up 200; 10uM; PC3; HT_HG-U133A | 4.09e-04 | 199 | 17 | 3 | 6307_UP | |
| Drug | Fluticasone propionate [80474-14-2]; Up 200; 8uM; MCF7; HT_HG-U133A | 4.09e-04 | 199 | 17 | 3 | 7348_UP | |
| Drug | Cefuroxime sodium salt [56238-63-2]; Down 200; 9uM; PC3; HT_HG-U133A | 4.09e-04 | 199 | 17 | 3 | 5787_DN | |
| Drug | Nadide [53-84-9]; Down 200; 6uM; PC3; HT_HG-U133A | 4.15e-04 | 200 | 17 | 3 | 5873_DN | |
| Drug | colchicine; Up 200; 0.1uM; MCF7; HG-U133A | 4.15e-04 | 200 | 17 | 3 | 644_UP | |
| Drug | phosphoramide mustard | 4.65e-04 | 43 | 17 | 2 | ctd:C030090 | |
| Drug | axitinib | 5.10e-04 | 45 | 17 | 2 | CID006450551 | |
| Drug | AC1L9IGI | 5.10e-04 | 45 | 17 | 2 | CID000445720 | |
| Drug | 2D7 | 6.04e-04 | 49 | 17 | 2 | CID005327103 | |
| Drug | U nu | 6.55e-04 | 51 | 17 | 2 | CID000023943 | |
| Disease | Lung diseases | 1.18e-05 | 78 | 17 | 3 | C0024115 | |
| Disease | gastrointestinal stromal tumor (is_implicated_in) | 1.71e-05 | 11 | 17 | 2 | DOID:9253 (is_implicated_in) | |
| Disease | multiple sclerosis symptom measurement | 3.19e-04 | 46 | 17 | 2 | EFO_0803536 | |
| Disease | granulocyte count | 3.92e-04 | 254 | 17 | 3 | EFO_0007987 | |
| Disease | carcinoma (implicated_via_orthology) | 6.17e-04 | 64 | 17 | 2 | DOID:305 (implicated_via_orthology) | |
| Disease | Adenocarcinoma of large intestine | 1.38e-03 | 96 | 17 | 2 | C1319315 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| SVKAYCWEEAMEKMI | 271 | P13569 | |
| CFEENMDWKMISDNY | 676 | Q86UQ4 | |
| HAMEKMEEFVCKVWE | 86 | Q86V24 | |
| PAEMYDIMKTCWDAD | 896 | P10721 | |
| NMEYMTWDDELEKSA | 76 | Q9H0B8 | |
| AEMEFNCEMKWKGKD | 31 | P35240 | |
| MDIMDYCKKEWRGNT | 86 | Q96BN8 | |
| EWKCAFMETSAKMNY | 141 | O95057 | |
| MKYKDKWATDQEDCS | 426 | O75128 | |
| ELYDIMKMCWKEKAE | 471 | P07948 | |
| EDSWPSDMCKKMFEV | 101 | P54317 | |
| DTKYCWKDEKDERMS | 376 | P0C2Y1 | |
| KETCEMDWSDKMEAY | 196 | Q8WW24 | |
| MDWSDKMEAYNIDET | 201 | Q8WW24 | |
| KSEMWDVFCYRMKDV | 2281 | Q8WWQ8 | |
| SDEMMKSYVAWDREK | 876 | P78527 | |
| MCDMKKWDQFYSEVL | 226 | Q9BY64 | |
| KESWMADYCKDDKDI | 2816 | Q5THJ4 |